News AZ's Tagrisso brings 'unprecedented' benefit in untreated NS... Drug could become standard of care, says AZ
Partner Content Partner Content Hear from five Nobel-winning scientists (for free) at Curiou... - Science conference “Curious2018 – Future Insight” in July looks to the future - Ceremony on May 3 another central event
News Incyte shares down sharply after phase 3 skin cancer trial f... Trial tested epacadostat pill in combination with Merck & Co’s Keytruda
Views & Analysis Digital health round-up: Blockchain, digital disruption and ... Richard Staines presents a weekly round-up of the latest developments in digital health
News IT playing key role in England's new cancer diagnosis centre... A series of cancer diagnosis 'one-stop shops' is being rolled out across England, with digital health technology playing an important role in hastening diagnosis.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
